Bitcoin 305.14
$8,247.10 3.7%
Ethereum 4.07
$175.38 2.32%
Zcash 0.57
$36.45 1.57%
Monero 2.19
$56.36 3.88%
Tether 0.00
$1.00 -0.28%
Stellar 0.00
$0.06 0.92%
Empowering Patients to Own Their Health Data

CRPT Rating: 2.1

  • Team & Advisory Board
  • Product & Research
  • Idea
  • Marketing
  • Investors Security
View Detailed Rating Website

Embleema’s blockchain network offers a novel way to put patients at the center of clinical research by letting them own their health data, disrupting the slow, costly, manual and opaque process by which low quality health data is currently collected by pharmaceutical companies through Contrat Research Organisation, to monitor the efficacy of new investigational drugs. Connecting patients directly to medical research and incentivizing them to share their data with tokens, blockchain is the decentralized technology everyone was waiting for to move away from the current linear process of drug approvals, to a new iterative model where trustworthy digital health data is shared in real time between patients, life sciences and regulators. The 21st Century Cures Act (2016) gave the FDA a mandate to accelerate approvals if more patient real world data was shared proactively by pharma. Embleema’s blockchain speeds up this process with patient buy-in, accelerating time to market new drugs.

Token Sale: 10 October — 01 January
Ticker
Token type
Whitelist
Min/Max Personal Cap
Accepts
Softcap
Hardcap

CRPT Rating (?) : 2.1


  • Team & Advisory Board
    • TEAM (1.8)
      • Leading Technological Experts (2)
      • Project Leader (1)
      • Development Team lead (1)
      • Marketing Lead (3)
      • Specification of experts work (3)
      • Experts Experience of in their spheres (2)
      • Presence of all necessary experts (1)
    • Advisory Board (1.9)
      • Popularity of advisors (3)
      • Expertise of advisors to the project profile (1)
  • Product Description & Marketing Research
    • Product Description (2.1)
      • Roadmap (1)
      • Detalization of product description (2)
      • Regularity of github commits (2)
      • Presence of product beta version (3)
      • Token description and role (2)
      • Discounts on goods and services (2)
      • Possibility of the project management via dao (2)
      • Devidents reception from tokens (2)
      • Buyout of tokens from investors (3)
      • Commision for tokens usage (3)
      • Profit calculation is present and adequate (3)
      • Financial plan detalization (2)
      • Tokens spending ratio (1)
    • Marketing Research (2.0)
      • Lack of competitors (1)
      • Lack of ready made products (1)
      • Presence of technological advantages (3)
      • The amount of financing attracted by competitors (3)
      • Dynamics of competitors growth (2)
      • Jurisdiction research (2)
      • Legal disclaimer for duties and obligations (2)
  • Idea (2.3)
    • Adequacy of the idea (2)
    • Originality of the idea (2)
    • Value of the idea for the community (3)
  • Marketing (2.5)
    • Website (3)
    • Social networks (3)
    • Marketing plan (2)
    • Marketing team (2)
    • Public presence of the team (2)
  • Investors Security (2.0)
    • Daico (2)
    • Decentralized escrow (2)



Short review
Number of team Members
Prototype
Team From

Add a Comment

Member of The Internet Defense League